Imaging Endpoints Files Patent for AI-Enhanced Imaging Review System
Imaging Endpoints has filed a provisional patent for its innovative AI-powered Imaging Review Charter (IRC) system, named AIRC System™, announced in a press release. This system aims to improve the customization and optimization of imaging review charters for oncology clinical trials.
The AIRC System addresses long-standing challenges in trial imaging design by integrating data from industry standards, published oncology criteria, and trial-specific information. It dynamically generates IRC documents tailored to each clinical trial, ensuring alignment with current regulatory requirements from agencies like the FDA and EMA.
Key features of the AIRC System include dynamic personalization, optimization of criteria, enhanced regulatory compliance, and increased efficiency. By leveraging AI, the system compiles and integrates applicable data, accelerating trial setup and delivering highly reliable results.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more